Kiersten Stead is a Managing Partner at DCVC Bio where she invests across Seed, Series A, Series B, and later stages in early-stage deep tech life sciences, including therapeutics, agriculture & food, industrial biotechnology, synthetic biology, and AI-assisted drug discovery. She is investing from a $400M fund raised in September 2024 and primarily backs companies in the United States. She serves on the boards of Nilo Therapeutics, Radionetics Oncology, Latus Bio, Totus Medicines, and MycoWorks, and has invested in companies like Totus Medicines, MycoWorks, Latus Bio, Elo Life Systems, and Novome Biotechnologies. Kiersten graduated from the University of Alberta and lives in San Francisco.
Kiersten Stead, Managing Partner @ DCVC Bio. Profile with intro opportunities and ranking information.
Not Yet Mapped
We've created a profile for Kiersten Stead from . Our ranking analysis and additional data will be available once our research is complete.
Rankings and detailed information coming soon
Network Strength
No ranking data available yet.
How to get an intro to Kiersten
Map your path to Kiersten instantly
Connect your network and Draftboard will automatically find and score the strongest paths to Kiersten
That's it. Draftboard does the rest.
Rankings based on connection strength analysis - we ONLY show aggregate data, never specific connection data.